Marcus A. Wörns - Concepedia

Author

Marcus A. Wörns

Johannes Gutenberg University Mainz

Also Known As

Marcus A Wörns, Marcus A. Worns, Marcus A. Wörns, Marcus A. Wörns, Marcus Alexander Wörns, Marcus Wörns, Marcus Wörns

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Johannes Gutenberg University Mainz University Medical Center of the Johannes Gutenberg University Mainz Heidelberg University University Hospital Heidelberg University of Bonn

About

Marcus A. Wörns is an author at Johannes Gutenberg University Mainz specializing in medicine, hepatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1K
2	Cell Biology	9	9	425
3	Health Sciences	1	1	20
4	Biochemistry	1	1	17
5	Gastroenterology	1	1	72

Marcus A. Wörns

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients Sarah Berhane, Hidenori Toyoda, Toshifumi Tada, Clinical Gastroenterology and Hepatology HepatologyBalad-2 Serologic ModelsMedicineHistopathologyPathology	2016	311
Concurrent Autoimmune Diseases in Patients With Autoimmune Hepatitis Andreas Teufel, Arndt Weinmann, George J. Kahaly, Journal of Clinical Gastroenterology	2010	212
Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation Nadine Gehrke, Nadine Hövelmeyer, Ari Waisman, Journal of Hepatology Liver FibrosisImmunologyPathologyIl1-ri AttenuatesCirrhosis	2018	169
Safety and Efficacy of Sorafenib in Patients With Advanced Hepatocellular Carcinoma in Consideration of Concomitant Stage of Liver Cirrhosis Marcus A. Wörns, Arndt Weinmann, Kerstin Pfingst, Journal of Clinical Gastroenterology	2009	146
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma – The SHELTER study Michael Bitzer, Marius Horger, Edoardo G. Giannini, Journal of Hepatology Shelter StudyOncologyHepatologyMedicineLiver Cancer	2016	134
Randomized Comparison of Selective Internal Radiotherapy (SIRT) Versus Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) for the Treatment of Hepatocellular Carcinoma Michael B. Pitton, Roman Kloeckner, Christian Ruckes, CardioVascular and Interventional Radiology	2014	118
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma Arndt Weinmann, Y Alt, Sandra Koch, BMC Cancer	2015	108
Regulation of B cell homeostasis and activation by the tumor suppressor gene <i>CYLD </i> Nadine Hövelmeyer, F. Thomas Wunderlich, Ramin Massoumi, The Journal of Experimental Medicine	2007	98
Trends in Epidemiology, Treatment, and Survival of Hepatocellular Carcinoma Patients Between 1998 and 2009 Arndt Weinmann, Sandra Koch, Ina M. Niederle, Journal of Clinical Gastroenterology	2013	92
Five Cases of<i>De Novo</i>Inflammatory Bowel Disease After Orthotopic Liver Transplantation Marcus A. Wörns, Ansgar W. Lohse, Markus F. Neurath, The American Journal of Gastroenterology Solid Organ TransplantationImmunologyGastroenterologyPathologyOrthotopic Liver Transplantation	2006	72

Page 1